United States · FDA National Drug Code directory
NYPOZI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-429_6951a2d4-8d07-4197-a02c-2e5aed420f33
- Product NDC
- 69097-429
- Form
- INJECTION
- Composition / generic term
- filgrastim-txid
- Labeler
- Cipla USA Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260211
- Source listing expiry
- 20271231
Source-listed ingredients
- FILGRASTIM — 480 ug/480ug
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (69097-429-67) / 480 ug in 1 SYRINGE, GLASS · 69097-429-67
- 10 SYRINGE, GLASS in 1 CARTON (69097-429-96) / 480 ug in 1 SYRINGE, GLASS · 69097-429-96
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →